In the world, unfortunately, still plenty of diseases that are not treatable. Patients are forced to take drugs for maintenance therapy to preserve their lives and health. The only hope is to develop new methods of disease control. For example, recently the specialists of the company Vactech, located in Finland, has introduced a vaccine that can prevent the development of diabetes mellitus type 1.
In the basis of development is research, held in the universities of the four major Finnish cities since 1994. During these surveys, scientists have revealed in newborns of risk factors predisposing to the development of diabetes. At the moment, the vaccine has been successfully tested on mice, and scientists from the Vactech prepare for full-scale research involving humans, which, according to experts, will last 2 to 4 years. If the efficiency of the new funds will be proved that the authors will receive a license for its sale, that too will take time. But at successful coincidence of circumstances market entry will not take more than 8 years. In addition, management Vactech signed a cooperation agreement with the American company Bio Provention to provide additional funding and accelerate work on a cure.
The vaccine itself will protect the person from certain infections caused by several enteroviruses. Because of them, according to scientists, and develops a series of defeats leading to the development of diabetes. Eliminating the first link of this “vicious nexus” can ensure that a large number of people will get this disease in the future.
In Finland created a vaccine against diabetes
Vladimir Kuznetsov